Literature DB >> 28730279

Potentially Inappropriate Antidepressant Prescriptions Among Older Adults in Office-Based Outpatient Settings: National Trends from 2002 to 2012.

Taeho Greg Rhee1,2, Jon C Schommer3, Benjamin D Capistrant4, Ronald L Hadsall3, Donald L Uden3.   

Abstract

Using data from 2002 to 2012 National Ambulatory Medical Care Survey, we estimated that the prevalence of overall antidepressant prescriptions increased almost twofold from 5.2% in 2002 to 10.1% in 2012 in office-based outpatient visits made by older adults. In addition, older adults were exposed to the risk of potentially avoidable adverse drug events in approximately one in ten antidepressant-related visits, or 2.2 million visits annually. Amitriptyline and doxepin were the two most frequent disease-independent potentially inappropriate antidepressants. Racial/ethnic minorities, and Medicaid beneficiaries had higher odds of potentially inappropriate antidepressant prescriptions (P < 0.05). Efforts to minimize potentially inappropriate antidepressant prescriptions are needed.

Entities:  

Keywords:  Antidepressant; Beers Criteria; Inappropriate use; Office-based care; Older adults; Prescribing pattern

Mesh:

Substances:

Year:  2018        PMID: 28730279     DOI: 10.1007/s10488-017-0817-y

Source DB:  PubMed          Journal:  Adm Policy Ment Health        ISSN: 0894-587X


  10 in total

1.  Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.

Authors:  Taeho Greg Rhee
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-11-13       Impact factor: 6.053

2.  Antipsychotic Prescriptions Among Adults With Major Depressive Disorder in Office-Based Outpatient Settings: National Trends From 2006 to 2015.

Authors:  Taeho Greg Rhee; Somaia Mohamed; Robert A Rosenheck
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 4.384

3.  Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Addiction       Date:  2019-07-25       Impact factor: 6.526

4.  Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  J Affect Disord       Date:  2019-04-08       Impact factor: 4.839

5.  National Prescribing Trends for High-Risk Anticholinergic Medications in Older Adults.

Authors:  Taeho Greg Rhee; Yookyung Christy Choi; Gregory M Ouellet; Joseph S Ross
Journal:  J Am Geriatr Soc       Date:  2018-03-26       Impact factor: 5.562

6.  Initiation of new psychotropic prescriptions without a psychiatric diagnosis among US adults: Rates, correlates, and national trends from 2006 to 2015.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Health Serv Res       Date:  2018-10-17       Impact factor: 3.402

7.  Continuing versus New Antidepressant Use in Older Adults: US Prescribing Trends from 2006 to 2015.

Authors:  Taeho Greg Rhee
Journal:  Eur Geriatr Med       Date:  2018-06-14       Impact factor: 1.710

8.  Psychotropic and Opioid-Based Medication Use among Economically Disadvantaged African-American Older Adults.

Authors:  Mohsen Bazargan; Sharon Cobb; Cheryl Wisseh; Shervin Assari
Journal:  Pharmacy (Basel)       Date:  2020-04-27

9.  Frequency and predictors of the potential overprescribing of antidepressants in elderly residents of a geographically defined U.S. population.

Authors:  William V Bobo; Brandon R Grossardt; Maria I Lapid; Jonathan G Leung; Cynthia Stoppel; Paul Y Takahashi; Robert W Hoel; Zheng Chang; Christian Lachner; Mohit Chauhan; Lee Flowers; Scott M Brue; Mark A Frye; Jennifer St Sauver; Walter A Rocca; Bruce Sutor
Journal:  Pharmacol Res Perspect       Date:  2019-01-23

10.  Effects of the 2009 USPSTF Depression Screening Recommendation on Diagnosing and Treating Mental Health Conditions in Older Adults: A Difference-in-Differences Analysis.

Authors:  Taeho Greg Rhee; Benjamin D Capistrant; Jon C Schommer; Ronald S Hadsall; Donald L Uden
Journal:  J Manag Care Spec Pharm       Date:  2018-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.